NO962503D0 - Use of penoxyphylline in the treatment of multiple sclerosis - Google Patents

Use of penoxyphylline in the treatment of multiple sclerosis

Info

Publication number
NO962503D0
NO962503D0 NO962503A NO962503A NO962503D0 NO 962503 D0 NO962503 D0 NO 962503D0 NO 962503 A NO962503 A NO 962503A NO 962503 A NO962503 A NO 962503A NO 962503 D0 NO962503 D0 NO 962503D0
Authority
NO
Norway
Prior art keywords
penoxyphylline
treatment
multiple sclerosis
sclerosis
Prior art date
Application number
NO962503A
Other languages
Norwegian (no)
Other versions
NO962503L (en
Inventor
Peter Rieckmann
Original Assignee
Rentschler Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel filed Critical Rentschler Arzneimittel
Publication of NO962503L publication Critical patent/NO962503L/en
Publication of NO962503D0 publication Critical patent/NO962503D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
NO962503A 1993-12-16 1996-06-13 Use of penoxyphylline in the treatment of multiple sclerosis NO962503D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4343034A DE4343034C1 (en) 1993-12-16 1993-12-16 Use of pentoxifylline for the treatment of multiple sclerosis
PCT/EP1994/004188 WO1995016450A1 (en) 1993-12-16 1994-12-16 Use of pentoxifyllin in the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
NO962503L NO962503L (en) 1996-06-13
NO962503D0 true NO962503D0 (en) 1996-06-13

Family

ID=6505251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962503A NO962503D0 (en) 1993-12-16 1996-06-13 Use of penoxyphylline in the treatment of multiple sclerosis

Country Status (10)

Country Link
EP (1) EP0734262A1 (en)
JP (1) JPH09506603A (en)
CA (1) CA2176848A1 (en)
CZ (1) CZ170896A3 (en)
DE (1) DE4343034C1 (en)
FI (1) FI962473A (en)
NO (1) NO962503D0 (en)
PL (1) PL314588A1 (en)
SK (1) SK76696A3 (en)
WO (1) WO1995016450A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544768C1 (en) * 1995-11-30 1997-07-10 Rentschler Arzneimittel Use of a combination of pentoxifylline with type I interferons to treat multiple sclerosis
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
AU2001262252A1 (en) * 2000-05-15 2001-11-26 Bayer Aktiengesellschaft Means for treating attacks of auto-immune diseases
US20070105878A1 (en) * 2005-10-03 2007-05-10 Andrew Reaume Purine formulations and methods for managing disorders
CN104870014A (en) * 2012-10-09 2015-08-26 比奥根Ma公司 Combination therapies and uses for treatment of demyelinating disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307883A1 (en) * 1992-03-12 1993-09-23 Westarp Martin Egon Dr Med Use of anti-retroviral substances - to treat motor-neuronal diseases
US5763446A (en) * 1992-03-26 1998-06-09 University Of Southern California Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases

Also Published As

Publication number Publication date
SK76696A3 (en) 1997-04-09
DE4343034C1 (en) 1995-06-08
EP0734262A1 (en) 1996-10-02
FI962473A0 (en) 1996-06-14
CA2176848A1 (en) 1995-06-22
JPH09506603A (en) 1997-06-30
NO962503L (en) 1996-06-13
FI962473A (en) 1996-07-16
PL314588A1 (en) 1996-09-16
WO1995016450A1 (en) 1995-06-22
CZ170896A3 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
DE59406123D1 (en) HAIR TREATMENT
DE69424016D1 (en) Polisher
DE69423581D1 (en) Polisher
FI944624A (en) 4-Arylaminobenzopyran and the like
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
DE69410520D1 (en) Treatment tank
NO971900D0 (en) Mixtures and treatment of multiple sclerosis
DE69418007T2 (en) Treatment tank
NO982463D0 (en) Use of a combination of pentoxyphylline and type I interferons for the treatment of multiple sclerosis
NO962503D0 (en) Use of penoxyphylline in the treatment of multiple sclerosis
NO965247D0 (en) Use of cross-linked hemoglobin in the treatment of subarakuoid hemorrhage
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
FI964809A0 (en) In the case of use of the processing unit
GB9222985D0 (en) Use of the tarchonanthus camphoratus
NO931399D0 (en) USE OF NATURSTEIN
NO942686D0 (en) Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychoses
DE59302194D1 (en) HAIR TREATMENT
KR940025597U (en) Outlet safeguard
NO944296D0 (en) Diamines in the treatment of arrhythmia
NO954115D0 (en) Use of ceruletide-diethylamine salt in the treatment of psoriasis
KR940020048U (en) Hair treatment
FI930700A0 (en) ANORDINATION OF THE AVLAEGSNANDE AV GOEDSEL
KR950000107U (en) Juicer of the juicer
HU9301386D0 (en) Multi-flowered lily of the valley
FI1295U1 (en) In the case of construction